INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 279 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,954,226 | -5.0% | 72,443 | -13.2% | 0.01% | -6.7% |
| Q1 2023 | $3,109,772 | +300.8% | 83,439 | +275.2% | 0.02% | +275.0% |
| Q4 2022 | $775,884 | -84.9% | 22,238 | -77.6% | 0.00% | -85.2% |
| Q2 2022 | $5,144,000 | +1.8% | 99,379 | +43.0% | 0.03% | -6.9% |
| Q1 2022 | $5,051,000 | -15.4% | 69,508 | +37.7% | 0.03% | -12.1% |
| Q4 2021 | $5,969,000 | -80.5% | 50,485 | -77.9% | 0.03% | -83.2% |
| Q3 2021 | $30,589,000 | +82.4% | 228,021 | +120.1% | 0.20% | +69.8% |
| Q2 2021 | $16,774,000 | +6229.8% | 103,603 | +2028.2% | 0.12% | +5700.0% |
| Q4 2020 | $265,000 | -47.6% | 4,868 | -80.9% | 0.00% | -50.0% |
| Q3 2020 | $506,000 | +69.2% | 25,440 | +24.8% | 0.00% | -33.3% |
| Q4 2019 | $299,000 | -44.5% | 20,382 | -38.1% | 0.01% | -60.0% |
| Q2 2019 | $539,000 | – | 32,916 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,216,340 | $62,958,000 | 7.04% |
| Discovery Value Fund | 584,483 | $30,253,000 | 6.33% |
| MPM BioImpact LLC | 299,409 | $15,497,000 | 4.30% |
| ARK Investment Management | 9,514,580 | $439,003,000 | 2.60% |
| Elmwood Wealth Management, Inc. | 67,899 | $3,514,000 | 2.00% |
| Nikko Asset Management Americas, Inc. | 2,781,136 | $141,143,000 | 1.74% |
| Avidity Partners Management LP | 1,125,194 | $58,240,000 | 1.34% |
| Merlin Capital, Inc | 12,174 | $630,000 | 1.26% |
| Atlas Venture Associates IX, LLC | 10,000 | $518,000 | 1.18% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $5,768,000 | 1.16% |